Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samia Mora

Showing results (21-30 of 260) with videos related to

Pageof 26
Sort By:
The American Journal of Cardiology|January 31, 2006
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?Samia Mora, Paul M Ridker
Archives of Internal Medicine|February 14, 2013
Fasting for lipid testing: is it worth the trouble?: comment on "fasting time and lipid levels in a community-based population"Amit V Khera, Samia Mora
Circulation Research|January 5, 2017
Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It HotPatrick R Lawler, Samia Mora
European Heart Journal|January 22, 2021
Lifelong low Lp(a) levels: genetics give a green light?Zareen M Farukhi, Samia Mora
Atherosclerosis|June 9, 2024
Diet quality, front-of-pack labeling, and lipoprotein particle profilesDanielle E Haslam, Samia Mora
JAMA|December 7, 2016
Shared Decision Making Regarding Aspirin in Primary Prevention of Cardiovascular Disease-ReplySamia Mora, JoAnn E Manson
Archives of Internal Medicine|February 14, 2013
Fasting for lipid testing: Is it worth the trouble?Amit V Khera, Samia Mora
JAMA Internal Medicine|September 18, 2013
Are there sex differences in acute coronary syndrome presentation?: a guide through the mazeAkintunde O Akinkuolie, Samia Mora
European Heart Journal|February 6, 2024
Lipoprotein(a) association with residual risk: what has inflammation got to do with it?Zareen M Farukhi, Samia Mora
JAMA Internal Medicine|June 21, 2016
Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and TreatmentSamia Mora, JoAnn E Manson
Pageof 26

Showing results (21-30 of 260) with videos related to

Sort By:
Pageof 26
The American Journal of Cardiology|January 31, 2006
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?Samia Mora, Paul M Ridker
Archives of Internal Medicine|February 14, 2013
Fasting for lipid testing: is it worth the trouble?: comment on "fasting time and lipid levels in a community-based population"Amit V Khera, Samia Mora
Circulation Research|January 5, 2017
Glycosylation Signatures of Inflammation Identify Cardiovascular Risk: Some Glyc It HotPatrick R Lawler, Samia Mora
European Heart Journal|January 22, 2021
Lifelong low Lp(a) levels: genetics give a green light?Zareen M Farukhi, Samia Mora
Atherosclerosis|June 9, 2024
Diet quality, front-of-pack labeling, and lipoprotein particle profilesDanielle E Haslam, Samia Mora
JAMA|December 7, 2016
Shared Decision Making Regarding Aspirin in Primary Prevention of Cardiovascular Disease-ReplySamia Mora, JoAnn E Manson
Archives of Internal Medicine|February 14, 2013
Fasting for lipid testing: Is it worth the trouble?Amit V Khera, Samia Mora
JAMA Internal Medicine|September 18, 2013
Are there sex differences in acute coronary syndrome presentation?: a guide through the mazeAkintunde O Akinkuolie, Samia Mora
European Heart Journal|February 6, 2024
Lipoprotein(a) association with residual risk: what has inflammation got to do with it?Zareen M Farukhi, Samia Mora
JAMA Internal Medicine|June 21, 2016
Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and TreatmentSamia Mora, JoAnn E Manson
Pageof 26